Improving clinical trial outcomes in amyotrophic lateral sclerosis

Individuals who are diagnosed with amyotrophic lateral sclerosis (ALS) today face the same historically intransigent problem that has existed since the initial description of the disease in the 1860s — a lack of effective therapies. In part, the development of new treatments has been hampered by an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Rev Neurol
Main Authors: Kiernan, Matthew C., Vucic, Steve, Talbot, Kevin, McDermott, Christopher J., Hardiman, Orla, Shefner, Jeremy M., Al-Chalabi, Ammar, Huynh, William, Cudkowicz, Merit, Talman, Paul, Van den Berg, Leonard H., Dharmadasa, Thanuja, Wicks, Paul, Reilly, Claire, Turner, Martin R.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://ncbi.nlm.nih.gov/pubmed/33340024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-00434-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares